The current supply of acceptable donor livers is not sufficient to meet the demands of listed patients awaiting transplantation resulting in thousands of deaths each year. Increased utilization of marginal livers may help alleviate this supply/demand mismatch by expanding the donor liver pool. The current status of liver transplantation using marginal donor grafts and efforts to optimize usage are discussed with attention to elderly donors, steatotic livers, donors after circulatory death, and split liver grafts.
Usage of “large‐for‐size” left lateral segment (LLS) liver grafts in children with high graft to recipient weight ratio (GRWR) is controversial due to concerns about increased recipient complications. During the study period 77 pediatric living donor liver transplants (LDLT) with LLS grafts were performed. We compared recipients with GRWR>2.5%(GR‐High=50) vs. GRWR0.0001). Graft (GR‐High: 98%,98%,98% vs. GR‐Low: 96%,93%,93%) and patient (GR‐High: 98%,98%,98% vs. GR‐Low: 100%,96%,96%) survival at 1,3 and 5 years was similar between groups (p=NS). Overall complications were also similar (34% vs 30%;p=0.8). Hepatic artery and portal vein thrombosis following transplantation was not different (p=NS). Delayed abdominal fascia closure was more common in GR‐High patients (17 vs. 1;p=0.002). Subgroup analysis comparing recipients with GRWR>4%(GR‐XL=20) to GRWR<2.5%(GRWR‐Low=27) revealed that delayed abdominal fascia closure was more common in the GR‐XL group, but postoperative complications, graft and patient survival were similar. We conclude that pediatric LDLT with large‐for‐size LLS grafts is associated with excellent clinical outcomes. There is an increased need for delayed abdominal closure with no compromise of long‐term outcomes. The use of high GRWR expands the donor pool and improves timely access to the benefits of transplantation without extra risks.
Split and LDLT in pediatric patients have the potential to decrease wait times and waitlist mortality. Using UNOS-STAR data, we compared outcomes of pediatric patients undergoing LDLT and SLT using LLS grafts. The baseline characteristics and post-operative outcomes were compared between groups. Actuarial graft and patient survival were analyzed with Kaplan-Meier curves. Between 2010 and 2019, 911 pediatric LT were included in the analysis (LD graft group, n = 508, split graft group, n = 403). LD graft recipients spent more time on the waitlist vs. the split graft group (60 (22–138) days vs. 46 (16–108) days; p = 0.007). LD recipients had a lower rate of graft failure, found in 9.8% of patients compared with 14.6% in the split graft group (p = 0.02). HAT was the most common graft failure cause, with similar rates. Graft and patient survival at 1-, 3-, and 5-years was comparable between LDLT and SLT. In subgroup analyses, patients with biliary atresia, those ≤10 kg or ≤10 years old receiving an LD graft showed improved graft survival. In conclusion, LDLT is associated with a lower rate of graft failure in pediatric patients. The use of LLS regardless of the type of donor is a safe way to facilitate access to transplantation to pediatric patients with acceptable short and long-term outcomes.